- Home
- FHTX vs HITI Comparison
FHTX vs HITI Comparison
Compare FHTX & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- HITI
- Stock Information
- Founded
- FHTX 2015
- HITI 2009
- Country
- FHTX United States
- HITI Canada
- Employees
- FHTX N/A
- HITI N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- HITI
- Sector
- FHTX Health Care
- HITI
- Exchange
- FHTX Nasdaq
- HITI Nasdaq
- Market Cap
- FHTX 237.4M
- HITI 219.4M
- IPO Year
- FHTX 2020
- HITI N/A
- Fundamental
- Price
- FHTX $4.10
- HITI $2.86
- Analyst Decision
- FHTX Strong Buy
- HITI Strong Buy
- Analyst Count
- FHTX 6
- HITI 1
- Target Price
- FHTX $13.17
- HITI $4.50
- AVG Volume (30 Days)
- FHTX 110.9K
- HITI 731.4K
- Earning Date
- FHTX 03-06-2025
- HITI 01-29-2025
- Dividend Yield
- FHTX N/A
- HITI N/A
- EPS Growth
- FHTX N/A
- HITI N/A
- EPS
- FHTX N/A
- HITI N/A
- Revenue
- FHTX $25,515,000.00
- HITI $374,815,931.00
- Revenue This Year
- FHTX N/A
- HITI $14.48
- Revenue Next Year
- FHTX $7.37
- HITI $16.50
- P/E Ratio
- FHTX N/A
- HITI N/A
- Revenue Growth
- FHTX N/A
- HITI 7.10
- 52 Week Low
- FHTX $2.81
- HITI $1.57
- 52 Week High
- FHTX $10.25
- HITI $3.62
- Technical
- Relative Strength Index (RSI)
- FHTX 38.20
- HITI 44.50
- Support Level
- FHTX $3.89
- HITI $2.55
- Resistance Level
- FHTX $4.64
- HITI $2.88
- Average True Range (ATR)
- FHTX 0.34
- HITI 0.16
- MACD
- FHTX 0.07
- HITI -0.03
- Stochastic Oscillator
- FHTX 30.77
- HITI 43.09
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker's Corner Ltd., Grasscity.com, Canna Cabana Inc., and KushBar Inc. The firm has established two main segments, retail and wholesale. It generates substantial revenue from retail stores' e-commerce platforms. Geographically it serves Canada, the USA, and other international markets and earns key revenue from domestic sales.